Metropolis Healthcare has informed that the Nomination and Remuneration Committee of the Board of Directors of the Company, at its meeting held today, Tuesday, November 03, 2026, has considered and approved: Grant of 24,060 (Twenty-Four Thousand and Sixty) units under the Metropolis - Restrictive Stock Units Plan, 2025; and 3,58,920 (Three Lakh Fifty-Eight Thousand Nine Hundred and Twenty) options under the Metropolis- Employees Stock Options Plan, 2025; Allotment of 65,600 (Sixty-Five Thousand and Six Hundred) equity shares at an exercise price of INR 2 (Indian Rupees Two only) each aggregating to INR 1,31,200 (Indian Rupees One Lakh Thirty-One Thousand Two Hundred only) against the Restrictive Stock Units (‘RSUs’) vested in and exercised by the employees of the Company under the MHL-RSU Plan, 2020. Further, the said equity shares shall rank pari-passu in all respects with the existing equity shares of the Company. The requisite details pertaining to the grant of stock benefits and allotment of equity shares are provided in Annexure I and Annexure II, respectively.
The above information is a part of company’s filings submitted to BSE.
